Exact Sciences
EXAS
#1783
Rank
C$12.95 B
Marketcap
$70.01
Share price
-2.28%
Change (1 day)
-14.40%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of September 2024 : C$9.41 Billion

According to Exact Sciences's latest financial reports the company's total assets are C$9.41 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$8.58 B1.58%
2022-12-31C$8.44 B-0.82%
2021-12-31C$8.51 B35.66%
2020-12-31C$6.27 B37.15%
2019-12-31C$4.57 B120.55%
2018-12-31C$2.07 B175.87%
2017-12-31C$0.75 B48.52%
2016-12-31C$0.50 B0.34%
2015-12-31C$0.50 B39.1%
2014-12-31C$0.36 B132.58%
2013-12-31C$0.15 B40%
2012-12-31C$0.11 B13.05%
2011-12-31C$98.62 M2.22%
2010-12-31C$96.47 M255.8%
2009-12-31C$27.11 M278.1%
2008-12-31C$7.17 M-50.75%
2007-12-31C$14.55 M-47.61%
2006-12-31C$27.78 M-36.93%
2005-12-31C$44.06 M-34.62%
2004-12-31C$67.39 M49.81%
2003-12-31C$44.98 M-43.13%
2002-12-31C$79.1 M-21.3%
2001-12-31C$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$1.51 B-83.92%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.77 B-81.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$30.84 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
C$194.13 B 1,961.10%๐Ÿ‡ซ๐Ÿ‡ท France